Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100 : A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE].
Bohn B, Bramlage P, Wagner C, Kaltheuner M, Welp R, Sziegoleit S, Zimmermann A, Reuter HM, Hummel M, Gloyer J, Holl RW, Danne T. Bohn B, et al. Among authors: zimmermann a. Wien Med Wochenschr. 2018 Nov;168(15-16):415-422. doi: 10.1007/s10354-017-0589-8. Epub 2017 Aug 21. Wien Med Wochenschr. 2018. PMID: 28828553 German.
Are insulin analogues detemir or glulisine used preferentially in overweight/obese subjects? A German multicentre analysis of 38560 type 2 diabetic patients from the DPV registry.
Bohn B, Scheuing N, Jehle PM, Laubner K, Born B, Merger S, Hummel M, Krakow D, Voll A, Zimmermann A, Zimny S, Holl RW; DPV and APV initiatives and the German BMBF Competence Networks Diabetes mellitus and Obesity. Bohn B, et al. Among authors: zimmermann a. Exp Clin Endocrinol Diabetes. 2014 Nov;122(10):602-7. doi: 10.1055/s-0034-1383646. Epub 2014 Jul 23. Exp Clin Endocrinol Diabetes. 2014. PMID: 25054308
Gender-specific Effects of Treatment with Lifestyle, Metformin or Sulfonylurea on Glycemic Control and Body Weight: A German Multicenter Analysis on 9 108 Patients.
Schütt M, Zimmermann A, Hood R, Hummel M, Seufert J, Siegel E, Tytko A, Holl RW; DPV initiative; German BMBF Competence Network Diabetes Mellitus. Schütt M, et al. Among authors: zimmermann a. Exp Clin Endocrinol Diabetes. 2015 Nov;123(10):622-6. doi: 10.1055/s-0035-1559608. Epub 2015 Aug 18. Exp Clin Endocrinol Diabetes. 2015. PMID: 26285070 Clinical Trial.
Association of antidiabetic therapies to glycemic control and to body weight in type 2 diabetes: a German multicenter analysis on 9294 patients.
Schütt M, Kern W, Zimmermann A, Busch P, Kerner W, Voll A, Wagner C, Kann PH, Dapp A, Holl RW; DPV initiative; German BMBF Competence Network Diabetes mellitus. Schütt M, et al. Among authors: zimmermann a. Exp Clin Endocrinol Diabetes. 2010 Aug;118(8):490-5. doi: 10.1055/s-0030-1249024. Epub 2010 Mar 3. Exp Clin Endocrinol Diabetes. 2010. PMID: 20200811
Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW; DPV Initiative. Schütt M, et al. Among authors: zimmermann a. Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):384-8. doi: 10.1055/s-2006-924152. Exp Clin Endocrinol Diabetes. 2006. PMID: 16915542
Progranulin and chemerin plasma level in obese patients with type 2 diabetes treated with a long-acting insulin analogue and premixed insulin analogue.
Waluga-Kozlowska E, Kuznik-Trocha K, Komosinska-Vassev K, Olczyk P, Jura-Poltorak A, Winsz-Szczotka K, Telega A, Ivanova D, Strzoda W, Zimmermann A, Janik M, Olczyk K, Waluga M. Waluga-Kozlowska E, et al. Among authors: zimmermann a. J Physiol Pharmacol. 2021 Dec;72(6). doi: 10.26402/jpp.2021.6.07. Epub 2022 Apr 2. J Physiol Pharmacol. 2021. PMID: 35377341 Free article.
1,467 results